GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Vendor] QST vs QYB on the same compound, same month — both cleared 99.0% — 62 comments in the full submission. View in context.
7.4k
c/tirzepatide·submitted 2 years ago by u/marta_dziedzic

[Vendor] QST vs QYB on the same compound, same month — both cleared 99.0%

Side Effectsbranch of 6 comments

Numbers in the title, numbers in the post. QST vs QYB on the same compound, same month — both cleared 99.0%. To save the first four comments: 99.0%. The step schedule question, answered properly, because it comes up weekly. The label sets a minimum interval of four weeks between increases. That is a floor on how fast…

Read the full submission and all 62 comments →

This branch

6 comments, started 2 years ago
u/ferritin_low309 points·2 years ago

The four-week interval in the label is a minimum. Nothing about the pharmacology requires you to step on schedule, and the trials stepped on a calendar because trials have to.

replysharereportpermalink
u/alcohol_aversion152 points·2 years ago

switching from sema is not a dose conversion, there is no clean equivalence

replysharereportpermalink
u/marta_dziedzicOP115 points·2 years ago

That percentage is body weight change, not body fat. Different measurement, and the distinction gets lost every time.

replysharereportpermalink
load more comments (3) →

← back to the whole thread

About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.